ArticleFolia microbiologica2025
Comparison of antibiotic resistance, virulence determinants, and biofilm formation in Pseudomonas aeruginosa isolated from intestinal carriers and clinical samples.
Article in Folia microbiologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Pseudomonas aeruginosa is an important opportunist pathogen responsible for community-acquired and nosocomial infections. The intestinal carriage of P. aeruginosa is likely due to its opportunistic nature. The aim of this study was to compare phenotypic and genotypic characteristics of P. aeruginosa recovered from stool of intestinal carriers with those isolated from various clinical specimens. Twenty- four fecal P. aeruginosa isolates obtained from 148 stool samples (74 healthy individuals and 74 patients with colonic disease) and 26 clinical P. aeruginosa isolates recovered from various clinical specimens other than stool, were investigated. Antimicrobial susceptibility, biofilm-forming ability using phenotypic methods and presence the exoY, algD, toxA, exoS, exoU, lasB, exoT genes were determined using polymerase chain reaction. The frequency of fecal carriage of P. aeruginosa was determined 16.2%. All fecal isolates were susceptible to ceftazidime and colistin, whereas all clinical isolates were susceptible only to colistin. There were no significant differences in multidrug- resistant (MDR) phenotypes between the clinical and fecal isolates. No significant differences in biofilm production were observed among isolates from healthy individuals compared with those from patients with colonic disease. However, differences were observed between clinical and fecal isolates regarding the presence of the algD and exoU genes (P ≤ 0.05). A significant difference was also found in the present of the exoU gene between MDR fecal and MDR clinical isolates (P = 0.007). The high prevalence of virulence factors in both fecal and clinical isolates emphasizes the importance of fecal P. aeruginosa as same as clinical isolates.
Indexed as
Identifiers
41284194What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.